The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M.-D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., & Raz, E. (1997) · Nature Medicine · doi:10.1038/nm0897-849 · Cited by 908
Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3026::aid-immu3026>3.0.co;2-h · Cited by 786
Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., & Samulski, R. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.791-801.2002 · Cited by 762
Immune responses to adenovirus and adeno-associated virus in humans
Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684
Recombinant adeno-associated virus for muscle directed gene therapy
Fisher, K. J., Jooss, K., Alston, J., Yang, Y., Haecker, S. E., High, K., Pathak, R., Raper, S. E., & Wilson, J. M. (1997) · Nature Medicine · doi:10.1038/nm0397-306 · Cited by 654
Virus treatment questioned after gene therapy death
Lehrman, S. (1999) · Nature · doi:10.1038/43977 · Cited by 576
Gene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Induction of Immune Tolerance to Coagulation Factor IX Antigen by In Vivo Hepatic Gene Transfer
Mingozzi, F., Liu, Y.-L., Dobrzynski, E., Kaufhold, A., Liu, J. H., Wang, Y., Arruda, V. R., High, K. A., & Herzog, R. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16887 · Cited by 466
O'Riordan, C. R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S. C., Smith, A. E., & Francis, G. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018021 · Cited by 409
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
Zaiss, A.-K., Liu, Q., Bowen, G. P., Wong, N. C. W., Bartlett, J. S., & Muruve, D. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4580-4590.2002 · Cited by 394
Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
Erles, K., Seb�kov�, P., & Schlehofer, J. R. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199911)59:3<406::aid-jmv22>3.0.co;2-n · Cited by 342
Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G.-P., Yu, Q. C., Qian, R., Chen, S.-J., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 342
Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration
Kay, M. A., Holterman, A.-X., Meuse, L., Gown, A., Ochs, H. D., Linsley, P. S., & Wilson, C. B. (1995) · Nature Genetics · doi:10.1038/ng1095-191 · Cited by 280
Moskalenko, M., Chen, L., van Roey, M., Donahue, B. A., Snyder, R. O., McArthur, J. G., & Patel, S. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1761-1766.2000 · Cited by 253
Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L., & Verma, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11377 · Cited by 244
Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
Zhong, L., Granelli-Piperno, A., Choi, Y., & Steinman, R. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<964::aid-immu964>3.0.co;2-p · Cited by 228
Immune responses to adeno-associated virus and its recombinant vectors.
Sun, J. Y., Anand-Jawa, V, Chatterjee, S., & Wong, K. K. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302039 · Cited by 215
Dendritic Cells: Controllers of the Immune System and a New Promise for Immunotherapy
BANCHEREAU, J., PACZESNY, S., BLANCO, P., BENNETT, L., PASCUAL, V., FAY, J., & PALUCKA, A. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06047.x · Cited by 208
Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA.
Yi, A., & KRIEG, A. M. (1998) · PubMed · Cited by 208
Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene Transfer
Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6199-6203.2001 · Cited by 207
Halbert, C. L., Standaert, T. A., Aitken, M. L., Alexander, I. E., Russell, D. W., & Miller, A. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5932-5941.1997 · Cited by 205
Halbert, C. L., Standaert, T. A., Wilson, C. B., & Miller, A. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9795-9805.1998 · Cited by 203
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
Sarkar, R., Tetreault, R., Gao, G., Wang, L., Bell, P., Chandler, R., Wilson, J. M., & Kazazian, H. H. (2004) · Blood · doi:10.1182/blood-2003-08-2954 · Cited by 201
Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression
Lo, W. D., Qu, G., Sferra, T. J., Clark, R., Chen, R., & Johnson, P. R. (1999) · Human Gene Therapy · doi:10.1089/10430349950018995 · Cited by 187
Rea, D., van Kooten, C., van Meijgaarden, K. E., Ottenhoff, T. H. M., Melief, C. J. M., & Offringa, R. (2000) · Blood · doi:10.1182/blood.v95.10.3162 · Cited by 184
Yang, Y., Su, Q., Grewal, I. S., Schilz, R., Flavell, R. A., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6370-6377.1996 · Cited by 181
Cutting Edge: Rapid Induction of Mitogen-Activated Protein Kinases by Immune Stimulatory CpG DNA
Yi, A.-K., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4493 · Cited by 175
Brockstedt, D. G., Podsakoff, G. M., Fong, L., Kurtzman, G., Mueller-Ruchholtz, W., & Engleman, E. G. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4724 · Cited by 165
Harms, J. S., & Splitter, G. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.10-1291 · Cited by 161
Macián, F., Im, S.-H., Garcı́a-Cózar, F. J., & Rao, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.013 · Cited by 158
Zsengellér, Z. K., Otake, K., Hossain, S.-A., Berclaz, P., & Trapnell, B. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9655-9667.2000 · Cited by 156
Manning, W. C., Zhou, S., Bland, M. P., Escobedo, J. A., & Dwarki, V. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.4-477 · Cited by 140
Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells
Wakimoto, H., Johnson, P. R., Knipe, D. M., & Chiocca, E. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302038 · Cited by 137
Song, X.-Y. R., Gu, M., Jin, W. W., Klinman, D. M., & Wahl, S. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2480 · Cited by 134
Development of adenovirus serotype 35 as a gene transfer vector
Reddy, P. S., Ganesh, S., Limbach, M. P., Brann, T. W., Pinkstaff, A., Kaloss, M., Kaleko, M., & Connelly, S. (2003) · Virology · doi:10.1016/s0042-6822(03)00161-2 · Cited by 129
Complement activation by recombinant adenoviruses
Cichon, G., Boeckh-Herwig, S., Schmidt, H., Wehnes, E., Müller, T. H., Pring‐Åkerblom, P., & Burger, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301611 · Cited by 128
Smith, T. A., White, B. D., Gardner, J. M., Kaleko, M., & McClelland, A. (1996) · PubMed · Cited by 126
Sarukhan, A., Camugli, S., Gjata, B., von Boehmer, H., Danos, O., & Jooss, K. U. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.269-277.2001 · Cited by 122
Zhang, Y., Chirmule, N., Gao, G.-P., & Wilson, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8003-8010.2000 · Cited by 119
Repeated Delivery of Adeno-Associated Virus Vectors to the Rabbit Airway
Beck, S. E., Jones, L. A., Chesnut, K. A., Walsh, S. M., Reynolds, T. C., Carter, B. J., Askin, F. B., Flotte, T. R., & Guggino, W. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9446-9455.1999 · Cited by 112
Reyes‐Sandoval, A., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.008 · Cited by 94
Ge, Y. C., Powell, S., Roey, M. V., & McArthur, J. G. (2001) · Blood · doi:10.1182/blood.v97.12.3733 · Cited by 89
Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain
Mastakov, M. Y., Baer, K., Symes, C. W., Leichtlein, C. B., Kotin, R. M., & During, M. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8446-8454.2002 · Cited by 87
Schauber, C., Tuerk, M., Pacheco, C. D., Escarpe, P., & Veres, G. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302170 · Cited by 79
Cottard, V., Valvason, C., Falgarone, G., Lutomski, D., Boissier, M., & Bessis, N. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000019781.64421.5c · Cited by 77
Self-citationChirmule, N. B., Hughes, J. V., Gao, G., Raper, S. E., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.6138-6145.1998 · Cited by 70
Anand, V., Duffy, B., Yang, Z., Dejneka, N. S., Maguire, A. M., & Bennett, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0525 · Cited by 69
Influence of immunosuppressive drugs on dendritic cells
Abe, M., & Thomson, A. W. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00050-9 · Cited by 68
Yasuda, K., Ogawa, Y., Kishimoto, M., Takagi, T., Hashida, M., & Takakura, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00210-3 · Cited by 68
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs
Chen, Y., Lenert, P. S., Weeratna, R. D., McCluskie, M. J., Wu, T., Davis, H. L., & Krieg, A. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301482 · Cited by 67
Liu, Y., Internati, M. C., Grizzi, F., Salati, E., Roman, J., Lim, S., & Hermonat, P. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700391 · Cited by 66
Xin, K.-Q., Ooki, T., Mizukami, H., Hamajima, K., Okudela, K., Hashimoto, K., Kojima, Y., Jounai, N., Kumamoto, Y., Sasaki, S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201662 · Cited by 65
Ritter, T., Brandt, C., Prösch, S., Vergopoulos, A., Vogt, K., Kolls, J. K., & Volk, H. (2000) · Cytokine · doi:10.1006/cyto.2000.0689 · Cited by 58
Harding, T., Koprivnikar, K., Tu, G., Zayek, N., Lew, S., Subramanian, A., Sivakumaran, A., Frey, D., Ho, K. I., VanRoey, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302142 · Cited by 57
Rafii, S., Dias, S., Meeus, S., Hattori, K., Ramachandran, R., Feuerback, F., Worgall, S., Hackett, N. R., & Crystal, R. G. (2001) · Circulation Research · doi:10.1161/hh0901.089884 · Cited by 31
Zhang, Y. C., Powers, M. A., Wasserfall, C. H., Brusko, T. M., Song, S., Flotte, T. R., Snyder, R., Potter, M., Scott-Jorgensen, M., Campbell‐Thompson, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302144 · Cited by 30
Onodera, M., Nelson, D., Sakiyama, Y., Candotti, F., & Blaese, R. M. (1999) · Acta Haematologica · doi:10.1159/000040930 · Cited by 27
Reduced toxicity of F-deficient Sendai virus vector in the mouse fetus
Waddington, S. N., Buckley, S. M. K., Bernloehr, C., Bossow, S., Ungerechts, G., Cook, T. H., Gregory, L. G., Rahim, A. A., Themis, M., Neubert, W., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302205 · Cited by 15
Effect of Adeno-Associated Virus–Specific Immunoglobulin G in Human Amniotic Fluid on Gene Transfer
Boyle, M., Enke, R. A., Mogayzel, P. J., Guggino, W. B., Martin, D. B., Agarwal, S., & Zeitlin, P. L. (2003) · Human Gene Therapy · doi:10.1089/104303403321208961 · Cited by 8
Cited by
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Therapeutic genome editing: prospects and challenges
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Metadata
- Authors
- Bessis, N., GarciaCozar, F. J., & Boissier, M.-C.
- Venue
- Gene Therapy
- Published
- 2004-09-29
- Volume
- 11
- Issue
- S1
- Pages
- S10-S17
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2042712894
- Cited by
- 633
- References
- 63
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.